Follow
Keying Ma
Keying Ma
Janssen Pharmaceutical Companies of Johnson and Johnson
Verified email at its.jnj.com
Title
Cited by
Cited by
Year
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
I Arijs, K Li, G Toedter, R Quintens, L Van Lommel, K Van Steen, ...
Gut 58 (12), 1612-1619, 2009
3992009
High affinity binding of β2-glycoprotein I to human endothelial cells is mediated by annexin II
K Ma, R Simantov, JC Zhang, R Silverstein, KA Hajjar, KR McCrae
Journal of Biological Chemistry 275 (20), 15541-15548, 2000
2892000
Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage in vitro
JH Lee, T Ort, K Ma, K Picha, J Carton, PA Marsters, LS Lohmander, ...
Osteoarthritis and Cartilage 17 (5), 613-620, 2009
1672009
Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study
MJ Loza, R Djukanovic, KF Chung, D Horowitz, K Ma, P Branigan, ...
Respiratory research 17 (1), 165, 2016
1402016
Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis
G Toedter, K Li, C Marano, K Ma, S Sague, CC Huang, XY Song, ...
The American journal of gastroenterology 106 (7), 1272, 2011
1062011
Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway
MA Judson, RM Marchell, MA Mascelli, A Piantone, ES Barnathan, ...
Journal of the American Academy of Dermatology 66 (6), 901-910. e2, 2012
872012
Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapy
G Toedter, K Li, S Sague, K Ma, C Marano, M Macoritto, J Park, R Deehan, ...
Inflammatory bowel diseases 18 (8), 1399-1410, 2012
562012
300 Guselkumab attenuates disease-and mechanism-related biomarkers in patients with moderate-to-severe plaque psoriasis
PJ Branigan, X Liu, Y Chen, K Ma, B Scott, P McGovern, E Munoz-Elias, ...
Journal of Investigative Dermatology 137 (5), S51, 2017
102017
CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
XY Song, C Huang, K Ma, B Liang, M Naso
US Patent 7,326,687, 2008
102008
The binding of beta (2)-glycoprotein I (beta (2) GPI) to endothelial cells is mediated through a high affinity interaction with annexin II.
K Ma, JC Zhang, K Wan, KA Hajjar, KR McCrae
Blood 92 (10), 172A-172A, 1998
31998
116 SERUM BIOMARKER STUDIES OF SYMPTOMATIC SUBJECTS WITH PERSISTENT KNEE PAIN WITH AND WITHOUT OA REVEAL SIGNIFICANT DIFFERENCES FROM ASYMPTOMATIC SUBJECTS IN SYSTEMIC MARKERS …
J Cibere, F Baribaud, K Ma, EC Sayre, N Prestley, H Wong, A Thorne, ...
Osteoarthritis and Cartilage 18, S59, 2010
2*2010
Resistin antagonists and their use
S Blake, J Carton, JH Lee, K Ma, P Marsters, K Picha, RS Xiao-yu, ...
US Patent App. 11/924,108, 2009
22009
Consistent Pharmacodynamic Effects of Sirukumab, an Anti-IL-6 Cytokine Monoclonal Antibody, on Serum Analytes Across Four Phase 3 Clinical Trials in Rheumatoid Arthritis
M Loza, K Sweet, N Peffer, C Franks, K Ma, K Campbell, M Sims, ...
ARTHRITIS & RHEUMATOLOGY 68, 2016
12016
Characterization of Molecular Response to Golimumab in Ulcerative Colitis by mRNA Expression Profiling: Results From Pursuit-SC Induction Study
K Li, S Telesco, PJ Rutgeerts, W Sandborn, CW Marano, K Ma, J Johanns, ...
GASTROENTEROLOGY 144 (5), S465-S466, 2013
12013
Su1745 Characterization of Molecular Response to Golimumab in Ulcerative Colitis by mRNA Expression Profiling: Results From Pursuit-SC Induction Study
K Li, S Telesco, PJ Rutgeerts, W Sandborn, CW Marano, K Ma, J Johanns, ...
Gastroenterology 144 (5), S-465-S-466, 2013
12013
W1228 Genes Associated With Reduced Epithelial Permeability and Epithelial-Mesenchymal Transition: Changes in Expression Following Infliximab Therapy in Ulcerative Colitis
G Toedter, K Ma, K Li, CW Marano, M Macoritto, J Park, RD Kenney, ...
Gastroenterology 138 (5), S-679, 2010
12010
Distinct Baseline Serum Molecular Profile and Pharmacodynamic Effects of Sirukumab, an Anti-IL-6 Cytokine Monoclonal Antibody, in Asian-Pacific Patients with Active Rheumatoid …
B Dasgupta, A Walsh, K Sweet, N Peffer, C Franks, K Ma, M Sims, ...
ARTHRITIS & RHEUMATOLOGY 68, 2016
2016
PTH-099 Distinctive Gene Expression Profiles in the Whole Blood of Patients with Moderate to Severe Ulcerative Colitis and Crohn’S Disease
S Telesco, K Li, C Marano, C Gasink, K Ma, R Strauss, C Brodmerkel
Gut 62 (Suppl 1), A251-A251, 2013
2013
PWE-084 Whole Blood MRNA Expression Profiling of Crohn’S Disease in the Certifi Ustekinumab Study Discriminates Clinical Subtypes
K Li, C Brodmerkel, S Telesco, K Ma, C Gasink
Gut 62 (Suppl 1), A164-A164, 2013
2013
Su1763 Distinctive Gene Expression Profiles in the Whole Blood of Patients With Moderate to Severe Ulcerative Colitis and Crohn's Disease
S Telesco, K Li, CW Marano, C Gasink, K Ma, R Strauss, C Brodmerkel
Gastroenterology 144 (5), S-470, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20